Accept: A Phase Ib/Ii Combination of Acalabrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop) for Patients With Diffuse Large B-Cell Lymphoma (Dlbcl)

Hematological Oncology - United Kingdom
doi 10.1002/hon.39_2629
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

CD5-positive Diffuse Large B-Cell Lymphoma Showing Prominent Intra-Sinusoidal Infiltration in the Bone Marrow, Successfully Treated With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone in Combination With Rituximab

Tenri Medical Bulletin
2013English

A Phase Ii Study of Lenalidomide and Rituximab (R²) Combination in Patients With High-Risk Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

British Journal of Haematology
Hematology
2016English

A Phase II Study of Ibrutinib in Combination With Rituximab-Cyclophosphamide-Doxorubicin Hydrochloride-Vincristine Sulfate-Prednisone Therapy in Epstein-Barr Virus-Positive, Diffuse Large B Cell Lymphoma (54179060LYM2003: IVORY Study): Results of the Final Analysis

Annals of Hematology
MedicineHematology
2020English

Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Gene Mutations and Copy Number Alterations (Cna) Predict for Early Failure in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Treated With R-Chop

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Lenalidomide and Obinutuzumab With Chop for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I/Ii Results

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

The Elevation of Cardio-Ankle Vascular Index in a Patient With Malignant Lymphoma Treated With a Combination Therapy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone

Journal of Clinical Medicine Research
2017English

Fourteen-Day Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop-14): Use It Right or Do Not Use It at All

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy